Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
1(7%)
Results Posted
22%(2 trials)
Terminated
2(13%)

Phase Distribution

Ph not_applicable
14
93%
Ph phase_4
1
7%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution15 total trials
Phase 4Post-market surveillance
1(6.7%)
N/ANon-phased studies
14(93.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

9 of 12 finished

Non-Completion Rate

25.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

15

all time

Status Distribution
Active(1)
Completed(9)
Terminated(3)
Other(2)

Detailed Status

Completed9
unknown2
Terminated2
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
1
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (6.7%)
N/A14 (93.3%)

Trials by Status

completed960%
withdrawn17%
unknown213%
active_not_recruiting17%
terminated213%

Recent Activity

Clinical Trials (15)

Drug Details

Intervention Type
OTHER
Total Trials
15